PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino) Quinazoline] as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi

This publication has 4 references indexed in Scilit:

• Relations Among Antimalarial Drugs: Results of Studies with Cycloguanil-, Sulfone-, or Chloroquine-Resistant Plasmodium Berghei in Mice
  The American Journal of Tropical Medicine and Hygiene, 1967
• Growth of Trypanosoma cruzi in Cultures of Chick Embryo Cells, and Effects of Furazolidone and Tris (p‐Aminophenyl)Carbonium Chloride
  The Journal of Protozoology, 1966
• Laboratory Studies on 4,6-Diamino-1-(p-Chlorophenyl)-1,2-Dihydro-2,2-Dimethyl-s-Triazine Pamoate (CI-501) as a Repository Antimalarial Drug
  The American Journal of Tropical Medicine and Hygiene, 1963
• AN EXPERIMENTAL DESIGN IN COMBINATION CHEMOTHERAPY
  Annals of the New York Academy of Sciences, 1958